Non-exclusive discount agreement for Clindamycin + Benzoyl Peroxide (ATC D10AF54)
Notice title: Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V zum Wirkstoff Clindamycin + Benzoylperoxid, ATC D10AF54 für die Zeit 01.01.2027 - 31.12.2028 (zzgl. V.-Option 1x12 Monate)
Non-exclusive discount agreement for the active ingredient Clindamycin + Benzoyl Peroxide (ATC D10AF54): Conclusion of a framework agreement with pharmaceutical companies under equal conditions, contract period from January 1, 2027, to December 31, 2028, with one 12-month extension option. Required documents include an offer letter, acceptance of DAK-Gesundheit's contractual terms and specified discounts, and completed Annexes 1 and 2 listing the relevant medicines. Submission of documents via email to openhouse@dak.de by the 5th of the preceding month for a contract start on the 1st or 15th of the following month. Further items as per the tender documents.
Never miss a tender again
We send you 3 current matches that fit your company.
Tender documents
- Portal — LOT-0001NON-RESTRICTED-DOCUMENT
- TED HTML — 797668-2026HTML
- TED PDF — 797668-2026PDF
- TED XML — 797668-2026XML
Unlock documents for free
Enter your email address. If you confirm, we will also send you 3 similar tenders.